Table 4 Showing comparison of metabolic and hormonal profile in diabetic subjects and non-diabetic controls on the basis of presence or absence of ultrasonic suggestion of polycystic ovaries (PCO).
Clinical parameter | Diabetic subjects | Controls | P(ANOVA) | ||
|---|---|---|---|---|---|
PCO (n = 64) | Non-PCO (n = 41) | PCO (n = 22) | Non-PCO (n = 38) | ||
Fasting glucose (mg/dl) | 123.8 ± 36.28 | 115.55 ± 32.0 | 92.14 ± 12.7 | 85.71 ± 14.6 | 0.000 |
Total cholesterol (mg/dl) | 189.4 ± 40.9 | 199.8 ± 57.0 | 183.27 ± 37.6 | 183.87 ± 41.3 | 0.375 |
Triglycerides (mg/dl) | 194.4 ± 69.9 | 192.4 ± 67.8 | 182.27 ± 52.1 | 187.65 ± 80.2 | 0.895 |
HDL cholesterol (mg/dl) | 42.0 ± 6.6 | 43.3 ± 8.8 | 44.00 ± 11.0 | 43.99 ± 7.6 | 0.593 |
LDL cholesterol (mg/dl) | 127.5 ± 55.2 | 131.1 ± 71.9 | 97.74 ± 40.7 | 105.76 ± 40.0 | 0.033 |
VLDL cholesterol (mg/dl) | 38.8 ± 13.9 | 38.4 ± 13.5 | 36.45+10.4 | 37.53+16.0 | 0.895 |
LH (IU/L) | 7.51+6.65 | 3.42 +2.21a | 7.93 ± 9.52 | 2.77 ± 2.17b | 0.000 |
FSH (IU/L) | 5.82+2.80 | 7.23+4.86 | 5.50 ± 2.3 | 5.11 ± 2.9 | 0.039 |
LH/FSH ratio | 1.31 ± 0.78 | 0.55 ± 0.26a | 1.3 ± 0.85 | 0.5 ± 0.26b | 0.000 |
Testosterone (ng/ml) | 37.4 ± 23.0 | 16.9 ± 7.3a | 39.6 ± 13.3 | 18.8 ± 7.5b | 0.000 |
Androstendione (ng/ml) | 2.40 ± 1.9 | 1.04 ± 0.36a | 2.10 ± 0.6 | 1.21 ± 0.40b | 0.000 |